Ten biotech companies were able to raise more than $500 million in combined financing in the past week. Here’s a recap of the funding activity, which spanned AI-based drug discovery, cell therapy clinical research, cancer drug development, and more.

Takeda has signed up for yet another multibillion-dollar gene therapy pact, this time encoding a $2 billion biobucks deal with little-known Code Biotherapeutics across four programs.